Thrombolytics (tPA) improve intermediate risk PE outcomes, with a few head bleeds (PEITHO Trial)
www.pulmccm.org
The use of thrombolytics for pulmonary embolism is not controversial -- that is, if the PE is massive with hypotension (give thrombolytics) or mild, with normal blood pressure and right ventricular function (don't give them). It's the patients with intermediate risk
Thrombolytics (tPA) improve intermediate risk PE outcomes, with a few head bleeds (PEITHO Trial)
Thrombolytics (tPA) improve intermediate risk…
Thrombolytics (tPA) improve intermediate risk PE outcomes, with a few head bleeds (PEITHO Trial)
The use of thrombolytics for pulmonary embolism is not controversial -- that is, if the PE is massive with hypotension (give thrombolytics) or mild, with normal blood pressure and right ventricular function (don't give them). It's the patients with intermediate risk